Qalsody (tofersen) - emergency pharmacy
Ended Awarded
- Contract number
- 36C26124N0621
- Awardee
-
Biogen U.s. Corporation UEI E82LHNZSCUA3
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $10,869
Award facts
- Contract value 100% obligated
- $10,869.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Cambridge, MA 02142, USA
Award details come from SAM.gov/FPDS.
About this award
This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Biogen U.S. Corporation, a biotechnology company focused on developing therapies for neurological diseases. It is a delivery order against Biogen's Pharmaceuticals and Drugs GSA Schedule contract, with a firm-fixed-price of $10,869.15. The contract is for the pharmaceutical product QALSODY (TOFERSEN), which is likely used to treat neurological conditions in veterans. This order was placed by the VA's Veterans Integrated Service Network 21. Biogen also holds two other notable contract vehicles with the VA: a single-award indefinite delivery contract worth up to $11.39 million for ranibizumab vials and syringes, and a Blanket Purchase Agreement worth up to $430,578.10 for the drug Spinraza, which is used to treat spinal muscular atrophy. These contract vehicles enable the VA to efficiently acquire necessary pharmaceuticals for veterans nationwide through December 2024.
Quick answers
Who was awarded contract 36C26124N0621?
36C26124N0621 was awarded to Biogen U.s. Corporation by Veterans Integrated Service Network 21 (Veterans Health Administration) on May 1, 2024.
How much is contract 36C26124N0621 worth?
The government has obligated $10,869 on 36C26124N0621.
Is contract 36C26124N0621 an order under another contract?
Yes. 36C26124N0621 is a delivery order under 36F79718D0566, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26124N0621 competed?
The extent of competition for 36C26124N0621 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award